Malaria - The Formidable Enemy of Humanity

Article Preview

Abstract:

Malaria, a disease caused by protozoan parasite of the genus Plasmodium, is an ancient enemy of the human race. Despite enormous efforts to control, it is still a main cause of morbidity and mortality in many endemic countries of the world, particularly Africa, South of Sahara. Malaria seems to be unstoppable due to lack of an effective vaccine, acquisition of drug-resistance by malaria parasite, and insecticide resistance by Anopheles mosquitoes. In this scenario, along with search for novel preventive approaches, adequate health facilities, health literacy and awareness among people are required to control and eliminate this formidable disease from society.

Info:

Pages:

1-5

Citation:

Online since:

July 2015

Authors:

Export:

Share:

Citation:

* - Corresponding Author

[1] P.L. Alonso, Malaria: deploying a candidate vaccine (RTS,S/AS02A) for an old scourge of humankind, Int. Microbiol. 9 (2006) 83-93.

Google Scholar

[2] A. Laveran, "Traite des fievres palusters", Doin, Paris, 1884.

Google Scholar

[3] P. Manson, On the nature and significance of the crecentic and flagellated bodies in malarial blood, Br. Med. J2 (1894) 1306-1308.

DOI: 10.1136/bmj.2.1771.1306

Google Scholar

[4] R. Ross, "Report on the cultivation of Proteosoma labbe in Grey Mosquitoes". Government press, Calcutta, 1898.

Google Scholar

[5] B. Grassi, A. Bignami, G. Bastianelli, Cido evolution delle semilune nell Anopheles claviger, Atti. Soc. Studi. Malar. 1 (1899) 14.

Google Scholar

[6] G. Bastianelli, A. Bignami, Sullo suilappo dei parassiti della terzana nell Anopheles claviger, Atti. Soc. Studi. Malar. 1 (1899) 28-49.

Google Scholar

[7] G. Raffaele, Un Ceppo italiano di Plasmodium elongatum, Riv. Malariol. 13 (1934) 3-8.

Google Scholar

[8] H.E. Shortt, P.C.C. Garnham, The pre-erythrocytic development of P. cyanomolgi and P. vivax, Trans. R. Soc. Trop. Med. Hyg. 41 (1948) 785-795.

Google Scholar

[9] H.E. Shortt, N.H. Feirley, G. Covell, P.G. Shute, P.C.C. Garnham, The pre-erythrocytic stages of Plasmodium falciparum, Trans. R. Soc. Trop. Med. Hyg. 44 (1951) 405-419.

DOI: 10.1016/s0035-9203(51)80019-1

Google Scholar

[10] C.J. Murray, L.C. Rosenfeld, S.S. Lim, K.G. Andrews, K.J. Foreman, D. Haring, N. Fullman, M. Naghavi, R. Lozano, A.D. Lopez, Global malaria mortality between 1980 and 2010: a systematic analysis, Lancet. 379 (2012) 413-431.

DOI: 10.1016/s0140-6736(12)60034-8

Google Scholar

[11] WHO, World malaria report, 2012, WHO press, Geneva, ISBN 978 92 4 156453 3, 2012.

Google Scholar

[12] C.B. Holmes, E. Losina, R.P. Walensky, Y. Yazdanpanah, K.A. Freedberg, Review of human immunodeficiency virus type 1-related opportunistic infections in sub-Saharan Africa, Clin. Infect. Dis. 36 (2003) 652−662.

DOI: 10.1086/367655

Google Scholar

[13] C. Flateau, G. Le Loup, G. Pialoux, Consequences of HIV infection on malaria and therapeutic implications: a systematic review, Lancet Infect. Dis. 11 (2011) 541–556.

DOI: 10.1016/s1473-3099(11)70031-7

Google Scholar

[14] WHO, World malaria report, 2011, WHO press, Geneva, ISBN 978 92 4 156440 3, 2011.

Google Scholar

[15] M.T. Al-Maktari, H.K. Bassiouny, Z.S. Al-Hamd, A.M. Assabri, A.G. El-Massry, H.Z. Shatat, Malaria status in Al-Hodeidah Governorate, Yemen: malariometric parasitic survey and chloroquine resistance P. falciparum local strain, J. Egypt. Soc. Parasitol. 33 (2003) 361–372.

Google Scholar

[16] K.M. Lekweiry, M.O. Abdallahi, H. Ba, C. Arnathau, P. Durand, J.F. Trape, A.O. Salem, Preliminary study of malaria incidence in Nouakchott, Mauritania, Malar. J. 8 (2009) 92–98.

DOI: 10.1186/1475-2875-8-92

Google Scholar

[17] J. Cox-Singh, T.M. Davis, K.S. Lee, S.S. Shamsul, A. Matusop, S. Ratnam, H.A. Rahman, D.J. Conway, B. Singh, Plasmodium knowlesi malaria in humans is widely distributed and potentially life threatening, Clin. Infect. Dis. 46 (2008) 165-171.

DOI: 10.1086/524888

Google Scholar

[18] J. Cox-Singh, B. Singh, Knowlesi malaria: newly emergent and of public health importance?, Trends. Parasitol. 24 (2008) 406–410.

DOI: 10.1016/j.pt.2008.06.001

Google Scholar

[19] R.N. Price, N.M. Douglas, N.M. Anstey, New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance, Curr. Opin. Infect. Dis. 22 (2009) 430-435.

DOI: 10.1097/qco.0b013e32832f14c1

Google Scholar

[20] J.-M. Kang, M. Sung-Ung, K. Jung-Yeon, C. Shin-Hyeong, K. Lin, S. Woon-Mok, K. Tong-Soo, N. Byoung-Kuk, Genetic polymorphism of merozoite surface protein-1 and merozoite surface protein-2 in Plasmodium falciparum field isolates from Myanmar, Malar. J. 9 (2010) 131.

DOI: 10.1186/1475-2875-9-131

Google Scholar

[21] M.M. Stevenson, R. Ing, F. Berretta, J. Miu, Regulating the adaptive immune response to blood-stage malaria: role of dendritic cells and CD4+Foxp3+ regulatory T cells, Int. J. Biol. Sci. 7 (2011) 1311-1322.

DOI: 10.7150/ijbs.7.1311

Google Scholar

[22] E. Tjitra, N.M. Anstey, P. Sugiarto, N. Warikar, E. Kenangalem, M. Karyana, D.A. Lampah, R.N. Price, Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia, PLoS. Med. 5e (2008) 128.

DOI: 10.1371/journal.pmed.0050128

Google Scholar

[23] K.E. Kester, J.F. Cummings, O. Ofori-Anyinam, C.F. Ockenhouse, U. Krzych, P. Moris, R. Schwenk, R.A. Nielsen, Z. Debebe, E. Pinelis, L. Juompan, J. Williams, M. Dowler, V.A. Stewart, R.A. Wirtz, M.C. Dubois, M. Lievens, J. Cohen, W.R. Ballou, D.G. Heppner, Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection, J. Infect. Dis. 200 (2009) 337–346.

DOI: 10.1086/600120

Google Scholar

[24] S.K. Prajapati, H. Joshi, V.K. Dua, Antigenic repertoire of Plasmodium vivax transmission-blocking vaccine candidates from the Indian subcontinent, Malar. J. 10 (2011) 111.

DOI: 10.1186/1475-2875-10-111

Google Scholar

[25] H.K. Heggenhouegen, V. Hackethal, P. Vivek, The behavioural and social aspects of malaria and its control, UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR), 2003.

DOI: 10.1016/0001-706x(92)90012-m

Google Scholar

[26] K. Raghavendra, T.K. Barik, B.P.N. Reddy, P. Sharma, A.P. Dash, Malaria vector control: from past to future, Parasitol. Res. 108 (2011) 757–779.

DOI: 10.1007/s00436-010-2232-0

Google Scholar

[27] J. Sachs, P. Malaney, The economic and social burden of malaria, Nature. 415 (2002) 680-685.

DOI: 10.1038/415680a

Google Scholar

[28] M.F. Good, Vaccine-induced immunity to malaria parasites and the need for novel strategies, Trends. Parasitol. 21(2005) 29-34.

DOI: 10.1016/j.pt.2004.10.006

Google Scholar

[29] C.E. Matisz, P. Naidu, S.E. Shokoples, D. Grice, V. Krinke, S.Z. Brown, K. Kowalewska-Grochowska, S. Houston, S.K. Yanow, Post-arrival screening for malaria in asymptomatic refugees using real time PCR, Am. J. Trop. Med. Hyg. 84 (2011) 161-165.

DOI: 10.4269/ajtmh.2011.10-0494

Google Scholar

[30] K. Artavanis-Tsakonas, J.E. Tongren, E.M. Riley, The war between the malaria parasite and the immune system: immunity, immunoregulation and immunopathology, Clin. Exp. Immunol. 133 (2003) 145-152.

DOI: 10.1046/j.1365-2249.2003.02174.x

Google Scholar

[31] M.B.B. McCall, R.W. Sauerwein, Interferon gamma-central mediator of protective immune responses against the pre-erythrocytic and blood stage of malaria, J. Leukoc. Biol. 88 (2010) 1131-1143.

DOI: 10.1189/jlb.0310137

Google Scholar

[32] A. Teklehaimanot, G.C. McCord, J.D. Sachs, Scaling up malaria control in Africa: an economic and epidemiological assessment, Am. J. Trop. Med. Hyg. 77 (2007) 138-144.

DOI: 10.4269/ajtmh.2007.77.138

Google Scholar

[33] P. Mocumbi, Plague of my people, Nature. 430 (2004) 925.

Google Scholar